Genetic Predisposition to Parkinson’s Disease and Cancer

E-ISSN： 1873-5576|14|3|310-321

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.14, Iss.3, 2014-03, pp. : 310-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Paths to Neurodegeneration in Genetic Parkinson's Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 9, 2014-11 ,pp. : 1485-1512

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic predisposition to cancer

By Turnbull Clare Hodgson Shirley

Clinical Medicine, Vol. 5, Iss. 5, 2005-09 ,pp. : 491-498

Royal College Of Physicians

Access to resources Recommend Favorite

Entacapone in the management of Parkinson’s disease

By Waters Cheryl Henchcliffe Claire

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 957-963

Informa Healthcare

Access to resources Recommend Favorite

Dopaminergic substitution in Parkinson’s disease

By Müller Thomas

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 10, 2002-10 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Dopamine agonists in Parkinson’s disease

By Tintner Ron Jankovic Joseph

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1803-1820

Informa Healthcare

Access to resources Recommend Favorite